Patents by Inventor Diane Amy Trainor

Diane Amy Trainor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide derivatives
    Patent number: 5907068
    Abstract: The invention concerns pharmaceutically useful trifluoromethyl ketone substituted di-, tri- and tetra-peptide derivatives of the formulae Ia, Ib, Ic set out hereinafter, and salts thereof which are inhibitors of human leukocyte elastase. Also described herein are pharmaceutical compositions containing a peptide derivative and processes and intermediates for use in the manufacture of the peptide derivatives.
    Type: Grant
    Filed: September 4, 1992
    Date of Patent: May 25, 1999
    Assignee: Zeneca Inc.
    Inventors: Mark Morris Stein, Diane Amy Trainor
  • Therapeutic N-(4-benzoyl-2-methyl-phenyl)-3,3,3-trifluoro-2-hydroxy-2-methyl-propana mides
    Patent number: 5900432
    Abstract: Compounds of formula I: ##STR1## wherein, ring C, A--B, R.sup.1, n, R.sup.2, and R.sup.3 have any of the meanings given in the specification, and their pharmaceutically acceptable salts are useful in the treatment of urinery incontinence. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
    Type: Grant
    Filed: October 12, 1995
    Date of Patent: May 4, 1999
    Assignee: Zeneca Limited
    Inventors: James Roy Empfield, Cyrus John Ohnmacht, Keith Russell, Diane Amy Trainor, Paul James Warwick, Jr.
  • Peptide derivatives
    Patent number: 5726158
    Abstract: The invention concerns pharmaceutically useful trifluoromethyl ketone substituted di-, tri- and tetra-peptide derivatives of the formulae Ia, Ib, Ic set out hereinafter, and salts thereof, which are inhibitors of human leukocyte elastase. Also described herein are pharmaceutical compositions containing a peptide derivative and processes and intermediates for use in the manufacture of the peptide derivatives.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 10, 1998
    Assignee: Zeneca Inc.
    Inventors: Philip Duke Edwards, John Anthony Schwartz, Mark Morris Stein, Diane Amy Trainor, Richard Alan Wildonger
  • Therapeutic agents
    Patent number: 5719166
    Abstract: Compounds of formula I, and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychiatric disorders such as psychoses; pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable diluent or carrier; and methods of treating neuropsychiatric disorders comprising administering to a mammal (including man) in need of such treatment an effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 15, 1996
    Date of Patent: February 17, 1998
    Assignee: Imperial Chemical Industries PLC
    Inventors: Robert Toms Jacobs, Cyrus John Ohnmacht, Diane Amy Trainor